Key points are not available for this paper at this time.
This study confirms that, among Ashkenazi OvC patients, BRCA1/2 mutations are associated with improved long-term survival. This may be due to distinct clinical behavior and/or to a better response to chemotherapy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Angela Chetrit
Galit Hirsh‐Yechezkel
Yehuda Ben‐David
Journal of Clinical Oncology
Tel Aviv University
Sheba Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Chetrit et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d9d83b84371aa676a3c0bf — DOI: https://doi.org/10.1200/jco.2007.11.6905